Lightning Round OT: Owens Illinois, Vivus and More
New Oriental Education : Take profits in EDU, Cramer said.
Owens-Illinois : OI is a buy, Cramer said.
Vivus :ImmunoGen is a better biotech speculation play, Cramer said.
Call Cramer: 1-800-743-CNBC
Questions for Cramer? firstname.lastname@example.org
Questions, comments, suggestions for the Mad Money website? email@example.com